Neurofibromatosis-1 Heterozygosity Increases Microglia in a Spatially and Temporally Restricted Pattern Relevant to Mouse Optic Glioma Formation and Growth

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/NEN.0b013e3182032d37PMID 21157378PMCID PMC3044783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

  2010cited by this paper
• Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice

  2009cited by this paper
• Optic Nerve Dysfunction in a Mouse Model of Neurofibromatosis-1 Optic Glioma

  2009cited by this paper
• Histopathologic predictors of pilocytic astrocytoma event-free survival

  2009cited by this paper
• Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)‐regulated glial proliferation

  2009cited by this paper
• Prognostic impact of CD68 and kallikrein 6 in human glioma.

  2009cited by this paper
• Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling.

  2009cited by this paper
• Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats.

  2009influential reference
• TNF‐α‐ and TRAIL‐resistant glioma cells undergo autophagy‐dependent cell death induced by activated microglia

  2009cited by this paper
• Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells.

  2008cited by this paper
• Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.

  2008cited by this paper
• Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.

  2008cited by this paper
• In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laser-induced damage in the fundus of the eye.

  2008cited by this paper
• Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.

  2008cited by this paper
• Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.

  2008cited by this paper
• Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

  2007cited by this paper
• Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.

  2007influential reference
• K-ras Is Critical for Modulating Multiple c-kit-Mediated Cellular Functions in Wild-Type and Nf1+/− Mast Cells1

  2007cited by this paper
• CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.

  2007cited by this paper
• Actin-binding Proteins Coronin-1a and IBA-1 are Effective Microglial Markers for Immunohistochemistry

  2007cited by this paper
• Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions

  2007cited by this paper
• The Chemokine CX3CL1 Reduces Migration and Increases Adhesion of Neurons with Mechanisms Dependent on the β1 Integrin Subunit1

  2006cited by this paper
• Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.

  2006cited by this paper
• Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.

  2006cited by this paper
• Isolation of murine microglial cells for RNA analysis or flow cytometry

  2006cited by this paper
• Mouse model for ablation of proliferating microgliain acute CNS injuries

  2006cited by this paper
• Tumor stroma and regulation of cancer development.

  2006cited by this paper
• Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma

  2006cited by this paper
• Natural history of neurofibromatosis 1–associated optic nerve glioma in mice

  2005cited by this paper
• Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation

  2005cited by this paper
• Role of microglia in the central nervous system's immune response

  2005cited by this paper
• CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin

  2005cited by this paper
• Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge

  2005cited by this paper
• Immunohistological study of mononuclear cell infiltrate in malignant gliomas

  2004cited by this paper
• Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation

  2004cited by this paper
• Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry

  2004cited by this paper
• Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.

  2003cited by this paper
• Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.

  2003cited by this paper
• Surface antigen changes during normal neutrophilic development: a critical review.

  2002cited by this paper
• Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation

  2002cited by this paper
• Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain.

  2002cited by this paper
• Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

  2002cited by this paper
• Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study

  2001cited by this paper
• A practical approach to multicolor flow cytometry for immunophenotyping.

  2000cited by this paper
• Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas

  2000cited by this paper
• Flow cytometric characterization of tumor-associated macrophages in experimental gliomas.

  2000cited by this paper
• Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion

  2000cited by this paper
• Tenascin Expression Patterns and Cells of Monocyte Lineage: Relationship in Human Gliomas

  2000cited by this paper
• Microglial/macrophage expression of interleukin 10 in human glioblastomas

  1999cited by this paper
• Microglia-specific localisation of a novel calcium binding protein, Iba1.

  1998cited by this paper
• Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance

  1998cited by this paper
• Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV‐seropositive patients and patients with other neurological disease

  1997cited by this paper
• Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes.

  1997influential reference
• Cancer dormancy: Opportunities for new therapeutic approaches

  1997cited by this paper
• Distribution and characterization of microglia/macrophages in human brain tumors

  1996cited by this paper
• Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history.

  1995cited by this paper
• Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.

  1995cited by this paper
• Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system.

  1991cited by this paper
• Antigen-specific damage to brain vascular endothelial cells mediated by encephalitogenic and nonencephalitogenic CD4+ T cell lines in vitro.

  1990cited by this paper
• Distribution of the CD68 macrophage/myeloid associated antigen.

  1990cited by this paper
• Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells

  1987cited by this paper
• Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.

  1987cited by this paper
• The tumor dormant state.

  1981cited by this paper

• Genetics and current research models of Mendelian tumor predisposition syndromes with ocular involvement

  2025cites this paper
• Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)

  2025cites this paper
• Interrogation of macrophage-related prognostic signatures reveals a potential immune-mediated therapy strategy by histone deacetylase inhibition in glioma

  2025cites this paper
• A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity

  2025cites this paper
• The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia

  2025cites this paper
• Involvement of microglia‐expressed MS4A6A in the onset of glioblastoma

  2024cites this paper
• Pediatric low-grade glioma models: advances and ongoing challenges

  2024cites this paper
• Microglia in Glioma.

  2024cites this paper
• Dynamics of microglia-glioblastoma crosstalk at the far infiltration zone

  2024cites this paper
• NF1+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1‐associated cognitive and motor impairment

  2024cites this paper
• An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies

  2024influential citation
• Glioblastoma microenvironment—from biology to therapy

  2024cites this paper
• MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models

  2024cites this paper
• The tumor micro-environment in pediatric glioma: friend or foe?

  2023cites this paper
• Pediatric low-grade glioma and neurofibromatosis type 1: A single-institution experience.

  2023cites this paper
• Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX®-Design Nanoparticles

  2023cites this paper
• Pediatric Glioma Models Provide Insights into Tumor Development and Future Therapeutic Strategies

  2023cites this paper
• Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.

  2023cites this paper
• Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects

  2023cites this paper
• Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.

  2023cites this paper
• Selective ADA2 inhibition for enhancing anti-tumor immune response in glioma: Insights from computational screening of flavonoid compounds.

  2023cites this paper
• Single-Cell Transcriptome Profiling Signatures and Alterations of Microglia Associated With Glioblastoma Associate Microglia Contribution to Tumor Formation

  2022cites this paper
• From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma

  2022cites this paper
• Neutrophils: New Critical Regulators of Glioma

  2022cites this paper
• LGG-50. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling

  2022cites this paper
• Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts

  2022cites this paper
• Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology

  2022cites this paper
• Human induced pluripotent stem cell modeling of neurofibromatosis type 1

  2022cites this paper
• The Benedict Arnold of the Central Nervous System Tumor Microenvironment? The Role of Microglia/Macrophages in Glioma.

  2021cites this paper
• Perspectives on Microglia-Based Immune Therapies Against Glioblastoma.

  2021cites this paper
• Regulation of Microglia for the Treatment of Glioma.

  2021cites this paper
• Microglia-Specific Expression of HEXA and HEXB Leads to Poor Prognosis in Glioblastoma Patients

  2021cites this paper
• New insights into low grade glioma tumor microenvironment for improved patient management.

  2021cites this paper
• Angeborene kutane Neurofibrome bei Neurofibromatose Typ 1: Klinisch‐pathologische Merkmale in der frühen Kindheit

  2021cites this paper
• Nitric oxide attenuates microglia proliferation by sequentially facilitating calcium influx through TRPV2 channels, activating NFATC2, and increasing p21 transcription

  2021cites this paper
• Wasl is crucial to maintain microglial core activities during glioblastoma initiation stages

  2021cites this paper
• Overcoming therapeutic resistance in glioblastoma: Moving beyond the sole targeting of the glioma cells

  2021cites this paper
• RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.

  2021cites this paper
• Congenital cutaneous neurofibromas in neurofibromatosis type 1: Clinicopathological features in early infancy

  2021cites this paper
• Reimagining Pilocytic Astrocytomas in the Context of Pediatric Low-Grade Gliomas.

  2021cites this paper
• PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response

  2020cites this paper
• A Glioblastoma Genomics Primer for Clinicians.

  2020cites this paper
• Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference

  2020cites this paper
• The Sociobiology of Brain Tumors.

  2020cites this paper
• Translating current basic research into future therapies for neurofibromatosis type 1

  2020cites this paper
• Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression

  2020cites this paper
• Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma

  2020cites this paper
• Digital commons

  2020cites this paper
• KIAA1549-BRAF Expression Establishes A Permissive Tumor Microenvironment Through NfÎob-Mediated CCL2 Production

  2020cites this paper
• The potential impacts of tylophora alkaloids and their derivatives in modulating inflammation, viral infections, and cancer.

  2019cites this paper
• Brain tumors in neurofibromatosis type 1

  2019cites this paper
• Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology.

  2019cites this paper
• An update on the central nervous system manifestations of neurofibromatosis type 1

  2019cites this paper
• Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI

  2019cites this paper
• Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1

  2019cites this paper
• The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis

  2019cites this paper
• Microglia as Dynamic Cellular Mediators of Brain Function.

  2019cites this paper
• Heterozygous Tumor Suppressor Microenvironment in Cancer Development.

  2019cites this paper
• Distinct Role of CD11b+Ly6G−Ly6C− Myeloid-Derived Cells on the Progression of the Primary Tumor and Therapy-Associated Recurrent Brain Tumor

  2019cites this paper
• Efficient and innocuous delivery of small interfering RNA to microglia using an amphiphilic dendrimer nanovector.

  2019cites this paper
• Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights

  2018cites this paper
• Human stem cell modeling in neurofibromatosis type 1 (NF1).

  2018cites this paper
• Tumor initiating cells induce Cxcr4-mediated infiltration of pro-tumoral macrophages into the brain

  2018influential citation
• MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia

  2018cites this paper
• Bidirectional Microglia–Neuron Communication in Health and Disease

  2018cites this paper
• Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1

  2018cites this paper
• Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis

  2018cites this paper
• KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production

  2018cites this paper
• Glioblastoma niches: from the concept to the phenotypical reality

  2018cites this paper
• Athymic mice reveal a requirement for T-cell–microglia interactions in establishing a microenvironment supportive of Nf1 low-grade glioma growth

  2018cites this paper
• Neurofibromatosis type 1.

  2018cites this paper
• Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors

  2018cites this paper
• Optic Pathway Gliomas in Neurofibromatosis Type 1

  2018cites this paper
• Microglia immunophenotyping in gliomas

  2017influential citation
• Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models

  2017cites this paper
• Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma–induced retinal pathology

  2017cites this paper
• Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.

  2017cites this paper
• The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer

  2017influential citation
• Perivascular niches as points of the utmost expression of tumor microenvironment

  2017cites this paper
• The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75NTR/CD271).

  2017cites this paper
• Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.

  2017cites this paper
• Neurofibromatosis type 1

  2017cites this paper
• NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

  2016cites this paper
• NF 1 germline mutation differentially dictates optic glioma formation and growth in neuro fi bromatosis-1

  2016cites this paper
• Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients

  2016cites this paper
• Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma

  2016cites this paper
• Contextual signaling in cancer.

  2016cites this paper
• NF 1 and the Praxitype

  2016cites this paper
• Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction

  2016cites this paper
• 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.

  2016cites this paper
• Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination

  2016cites this paper
• RNA‐sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease

  2015cites this paper
• Microglia in the tumor microenvironment: taking their TOLL on glioma biology.

  2015cites this paper
• Pediatric gliomas as neurodevelopmental disorders

  2015cites this paper
• The role of microglia and macrophages in glioma maintenance and progression

  2015cites this paper
• RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth

  2015influential citation
• Neurofibromatosis type 1.

  2015cites this paper
• Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1

  2015cites this paper
• Raf/MEK/ERK Signaling

  2015cites this paper
• RASopathies: unraveling mechanisms with animal models

  2015cites this paper